EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Three‐year outcomes of repeated botulinum neurotoxin A injections to the lower extremities in young children with spastic cerebral palsy in GMFCS levels I to III

Darcy Fehlings iD, Emma Bohn iD, Lauren Switzer, Charles H Goldsmith, Unni Narayanan iD, Peter L Rosenbaum iD, F Virginia Wright iD, Gary Foster, CP‐BoNT‐A Study Group

Developmental Medicine & Child Neurology · 2026

DOI: 10.1111/dmcn.70031 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Developmental Medicine & Child Neurology, 2026. Verfasst von Darcy Fehlings und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Faculty of Medicine, University of Toronto, …. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Cerebral Palsy, Neuromuscular Agents, Lower Extremity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institute of Health Research, Institute of Human Development, Child and Youth Health, Institute of Human Development, Child and Youth Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate the effectiveness of repeated botulinum neurotoxin A (BoNT‐A) injections on gross motor function over 3 years in ambulant children with spastic cerebral palsy (CP).

Method

A prospective observational cohort study of 124 participants was conducted comparing outcomes in children (aged 2–6 years) with spastic CP functioning in Gross Motor Function Classification System (GMFCS) levels I to III who did and did not receive BoNT‐A. The primary outcome was the 66‐item Gross Motor Function Measure (GMFM‐66), assessed at baseline and annually over 3 years. Secondary outcomes included passive ankle dorsiflexion with knee extended (PADKE) and several measures of activity and participation.

Results

A total of 117 participants (94%), consisting of 61 cases and 56 comparisons, were assessed on the GMFM‐66 at a follow‐up of 1 year or longer, with 106 (85%) assessed at year 3. There were no significant differences in mean GMFM‐66 scores adjusted for baseline differences between groups over time ( β̂ group = 0.92, standard error [SE] = 0.81, 95% confidence interval [CI] = − 0.66 to 2.50; p = 0.256). A difference in PADKE favouring the comparison group was observed ( β̂ group = − 4.17, SE = 1.58, 95% CI = − 7.27 to − 1.08; p = 0.009), approaching the 5° minimally important difference.

Interpretation

Repeated BoNT‐A injections over 3 years were not associated with improvements in gross motor function or passive ankle dorsiflexion range in young children with spastic CP functioning in GMFCS levels I to III compared to a comparison group not receiving BoNT‐A.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ACerebral PalsyNeuromuscular AgentsLower ExtremityOutcome Assessment, Health CareHumansMaleFemaleChildChild, PreschoolTreatment OutcomeProspective StudiesSeverity of Illness IndexFollow-Up Studies

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Department of Paediatrics, Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto, ON, Canada.
  • Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamiton, ON, Canada.
  • Department of Surgery, University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada.
  • CanChild Centre for Childhood-Onset Disability, Department of Pediatrics, McMaster University, Hamilton, ON, Canada.
  • Department of Physical Therapy, Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, University of Toronto, Toronto, ON, Canada.

ORCID-Profile: Darcy Fehlings, Emma Bohn, Unni Narayanan, Peter L Rosenbaum, F Virginia Wright

Förderung

  • Canadian Institute of Health Research, Institute of Human Development, Child and Youth Health
  • Institute of Human Development, Child and Youth Health

Zitieren

APA

Fehlings, D., Bohn, E., Switzer, L., Goldsmith, C. H., Narayanan, U., Rosenbaum, P. L., Wright, F. V., Foster, G., & CP‐BoNT‐A Study Group (2026). Three‐year outcomes of repeated botulinum neurotoxin A injections to the lower extremities in young children with spastic cerebral palsy in GMFCS levels I to III. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.70031

Vancouver

Fehlings D, Bohn E, Switzer L, Goldsmith CH, Narayanan U, Rosenbaum PL, et al. Three‐year outcomes of repeated botulinum neurotoxin A injections to the lower extremities in young children with spastic cerebral palsy in GMFCS levels I to III. Developmental Medicine & Child Neurology. 2026. doi:10.1111/dmcn.70031

BibTeX
@article{Fehlings2026,
  author = {Fehlings, Darcy and Bohn, Emma and Switzer, Lauren and Goldsmith, Charles H and Narayanan, Unni and Rosenbaum, Peter L and Wright, F Virginia and Foster, Gary and CP‐BoNT‐A Study Group, CP‐BoNT‐A Study Group},
  title = {Three‐year outcomes of repeated botulinum neurotoxin A injections to the lower extremities in young children with spastic cerebral palsy in GMFCS levels I to III},
  journal = {Developmental Medicine & Child Neurology},
  year = {2026},
  doi = {10.1111/dmcn.70031}
}
Kostenlos starten →